Pasinex Logo.png
Pasinex Announces Filing of 2024 Second Quarter Financial Results
August 29, 2024 07:59 ET | Pasinex Resources Limited
Pasinex Resources Limited has filed its financial statements, management's discussion and analysis, and related certifications for the three and six months
XORTX Logo.jpg
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
August 29, 2024 07:00 ET | XORTX Therapeutics Inc.
● Xanthine oxidase reported to modulate progression of chronic kidney disease, diabetic kidney disease, polycystic kidney disease, and other indications ● CALGARY, Alberta, Aug. 29, 2024 ...
Six-time MLB All-Star, three-time Silver Slugger, and Olympic medal winner José Bautista
Mikra Ships FOCUS Ahead of Schedule and Prepares for Marketing Push
August 29, 2024 07:00 ET | Lifeist Wellness Inc.
Mikra ships Focus preorders ahead of schedule, prepares for September marketing push
MDG_LOGO_2016_GRAY_RGB.jpg
Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
August 29, 2024 05:00 ET | Medigene AG
Planegg/Martinsried, August 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Hydreight-02_horizontal-01 (1) (002).jpg
Hydreight Reports Record Topline¹ Revenue of $5.59M in Q2-2024 (YOY Increase of 27%) and positive Adjusted EBIDTA¹
August 28, 2024 19:32 ET | Hydreight Technologies Inc.
“We had another outstanding quarter with record revenue and positive Adjusted EBITDA...Our focus in 2024 is to continue growing revenue, being a profitable company and introducing our story to more...
Avicanna_Logo_Colour_WithTM-01.png
Avicanna Announces Closing of Non-Brokered Private Placement
August 28, 2024 18:15 ET | Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
EMN_logo.png
Euro Manganese Submits Application for Strategic Project Status under EU’s Critical Raw Materials Act
August 28, 2024 17:40 ET | Euro Manganese Inc.
HIGHLIGHTS Submitted application to designate Chvaletice Manganese Project as a Strategic Project under the EU’s Critical Raw Materials Act (CRMA)CRMA is designed to sustainably ensure availability...
QLogo_Primary_RGB_1000x843 (1).jpg
Partnerschaft für Begleitdiagnostika für chronische Krankheiten: QIAGEN weitet Anwendung von QIAstat-Dx auf die Präzisionsmedizin aus
August 28, 2024 16:05 ET | QIAGEN N.V.
Neue Vereinbarung erweitert die Zusammenarbeit mit AstraZeneca über die Onkologie hinaus - einschließlich komplexer chronischer Erkrankungen // QIAGENs syndromische Testplattform QIAstat-Dx ermöglicht...
QIAGEN expands QIAst
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
August 28, 2024 16:05 ET | QIAGEN N.V.
Venlo, the Netherlands, Aug. 28, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its Master Collaboration Agreement with AstraZeneca to...